RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Simulations Plus Stock

Simulations Plus Stocks 2025

Simulations Plus Stocks

20.3 M

Ticker

SLP

ISIN

US8292141053

WKN

924294

In 2025, Simulations Plus had 20.3 M outstanding stocks, a 0% change from the 20.3 M stocks in the previous year.

The Simulations Plus Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2030e20.3
2029e20.3
2028e20.3
2027e20.3
2026e20.3
2025e20.3
202420.3
202320.47
202220.75
202120.74
202018.54
201918.06
201817.86
201717.52
201617.21
201517.03
201416.41
201316.32
201216.15
201116.08
201016.51
200917.19
200818.14
200717.96
200616.29
200515.92

Simulations Plus shares outstanding

The number of shares was Simulations Plus in 2024 — This indicates how many shares 20.301 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Simulations Plus earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Simulations Plus's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Simulations Plus’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Simulations Plus's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Simulations Plus Aktienanalyse

What does Simulations Plus do?

Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Simulations Plus's Shares Outstanding

Simulations Plus's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Simulations Plus’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Simulations Plus’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Simulations Plus’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Simulations Plus stock

How many stocks are there of Simulations Plus?

The current number of stocks of Simulations Plus is 20.3 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Simulations Plus are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Simulations Plus evolved in recent years?

The number of shares of Simulations Plus has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Simulations Plus as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Simulations Plus?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Simulations Plus pay?

Over the past 12 months, Simulations Plus paid a dividend of 0.24 USD . This corresponds to a dividend yield of about 0.71 %. For the coming 12 months, Simulations Plus is expected to pay a dividend of 0.25 USD.

What is the dividend yield of Simulations Plus?

The current dividend yield of Simulations Plus is 0.71 %.

When does Simulations Plus pay dividends?

Simulations Plus pays a quarterly dividend. This is distributed in the months of November, March, May, August.

How secure is the dividend of Simulations Plus?

Simulations Plus paid dividends every year for the past 0 years.

What is the dividend of Simulations Plus?

For the upcoming 12 months, dividends amounting to 0.25 USD are expected. This corresponds to a dividend yield of 0.73 %.

In which sector is Simulations Plus located?

Simulations Plus is assigned to the 'Health' sector.

Wann musste ich die Aktien von Simulations Plus kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Simulations Plus from 8/5/2024 amounting to 0.06 USD, you needed to have the stock in your portfolio before the ex-date on 7/29/2024.

When did Simulations Plus pay the last dividend?

The last dividend was paid out on 8/5/2024.

What was the dividend of Simulations Plus in the year 2024?

In the year 2024, Simulations Plus distributed 0.24 USD as dividends.

In which currency does Simulations Plus pay out the dividend?

The dividends of Simulations Plus are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Simulations Plus

Our stock analysis for Simulations Plus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Simulations Plus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.